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Abstract Transgenic animals of the line 8 contain the WAP- 
SV-T transgene. Females of this line synthesise the SV40 T- 
antigen in mammary gland epithelial cells during pregnancy and 
the lactation period. All females are 'milk-less' and the offspring 
have to be nursed by foster mothers. The reason for this phenom- 
enon is a premature apoptosis during late pregnancy. Nonetheless 
a significant number of mammary epithelial cells escape apoptosis 
and all transgenic females develop breast cancer after the first 
lactation period. 
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1. Introduction 
During each pregnancy and lactation cycle, the mammary 
glands of rodents undergo an extensive differentiation process 
followed by gland involution after weaning. The glands of vir- 
gin animals contain exclusively adipose cells. During preg- 
nancy, these cells are replaced by highly differentiated pithelial 
cells which form the alveolar and ductal structures that 
monopolise the gland during the lactation period. At this stage, 
mammary tissue accounts for about 20% of the body weight. 
Mammary gland development and milk protein synthesis (e.g. 
whey acidic protein) are under the control of various lactotro- 
phic hormones (e.g. estrogen, progesterone, prolactin, insulin, 
hydrocortisone) and local growth factors. Shortly after lacta- 
tion, the milk protein genes are switched off and the epithelial 
cells are again replaced by adipose cells [1-5]. Through this 
pre-programmed cell death (apoptosis) nearly 90% of the mam- 
mary mass is removed within a few days. The pre-programmed 
cell death seems to be a balanced cooperation between different 
genes that either promote or inhibit apoptosis [6]. We recently 
generated transgenic animals which carry the early SV40 cod- 
ing region (T/t-antigen) under the transcriptional control of the 
whey acidic milk protein promoter (WAP-SV-T). Expression of 
the WAP-SV-T transgene occurs during pregnancy and the 
lactation period as demonstrated byimmunofluorescence stain- 
ing and Northern blot analysis [7]. After lactation, expression 
of the WAP-SV-T transgene continues in epithelial cells which 
escape mammary gland involution and as a consequence, all 
transgenic females develop breast cancer after the first preg- 
nancy. Furthermore, all animals have a reduced lactation ca- 
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pacity and the offspring have to be nursed by foster mothers. 
The reason for this 'milk-less' phenomenon could be either an 
underdevelopment of the mammary glands during pregnancy 
or a premature mammary gland involution. 
In this investigation we obtained experimental evidence that 
the SV40 T-antigen induces apoptosis during late pregnancy 
which causes involution of the mammary glands before birth 
of the litters. 
2. Material and methods 
2.1. Animals 
Transgenic animals (strain: NMRI) carrying the WAP-SV-T trans- 
gene (WAP-promoter and the early SV40 BglI/BamHI DNA fragment) 
were generated as described elsewhere [7]. The 1.6 kb WAP promoter 
was kindly provided by Dr. L. Henninghausen. 
2.2. DNA fragmentation 
DNA was extracted as described elsewhere [8]. In short, tissue seg- 
ments were homogenised and then digested with Proteinase K ( 1 mg/ml, 
Boehringer Mannheim) in 1 ml of digestion buffer at 55°C for 20 hours. 
DNA (5 ~tg) was subjected to agarose gel electrophoresis (1.5% agarose 
gel 60 mA; running buffer: Tris-HC1 40 mM, Na-acetate 5 mM, EDTA 
1 mM, pH 7.9). DNA fragmentation was visualised by ethidium bro- 
mide staining. 
2.3. Histology 
Mammary tissue segments were fixed in 10% formalin in phosphate- 
buffered saline (PBS) and defatted in acetone. After dehydration by 
means of graded concentrations of alcohol solutions, tissue segments 
were embedded in paraffin. Thin sections (4-6 ,um) were stained with 
hematoxylin and eosin or Hoechst dye 33258 (8 ¢tg/ml). 
3. Results and discussion 
Transgenic animals of the line 8 carry the WAP-SV-T trans- 
gene. This hybrid gene contains the early SV40 coding region 
(BglI/BamHl DNA fragment) and the whey acidic protein- 
promoter. To test whether the 'milk-less' phenomenon of the 
transgenic animals is caused by an under-development of he 
mammary glands, tissue segments were isolated from normal 
and transgenic animals on the first day of the lactation period. 
As shown in Fig. I C, the under-development of the trans- 
genic gland is evident. In this gland the adipose cells are the 
dominant cell type occupying about 40-50% of the entire gland 
tissue. In contrast, in the mammary gland of the normal animal 
few adipose cells are demonstrable and the epithelial cells are 
the dominant cell type, forming the lobuloalveolar structure of 
the gland (Fig. ID). This observation implies that the SV40 
T-antigen impairs the development of the mammary gland dur- 
ing pregnancy. To prove this histological sections were pre- 
pared from normal and transgenic animals on various days 
during pregnancy. We observed, however, that the mammary 
glands of the transgenic animals exhibited a higher degree of 
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Fig. 1. Histology of mammary glands from transgenic and normal animals. Tissue segments were isolated: (A) from a transgenic animal at the day 
18 of pregnancy; (B) from a normal animal at the day 18 of pregnancy; (C) from a transgenic animal at the first day of lactation; (D) from a normal 
animal at the first day of lactation. 
development in late pregnancy than did those of the normal 
animals. As shown in Fig. 1A, on day 18 of pregnancy the 
mammary gland of the transgenic animals contained mainly 
epithelial cells while the gland of the normal animal still con- 
tained more adipose cells than epithelial cells (Fig. 1B). This 
observation i dicates that the SV40 T-antigen stimulates ep- 
ithelial cell proliferation rather than causing inhibition of cell 
division. This was not entirely unexpected since it is well docu- 
mented that the SV40 T-antigen is a strong mitogen, inducing 
DNA replication and cell division in a wide spectrum of differ- 
ent cell types [9]. It is, therefore, more likely that T-antigen 
mediates a premature mammary gland involution during late 
pregnancy. 
In normal animals, mammary gland involution takes place 
two to three days post-weaning, accompanied by a progressive 
decrease of WAP mRNA synthesis and replacement of the 
epithelial cells by adipocytes. About four to six days after wean- 
ing, the morphology and the expression rate of the milk genes 
(e.g. WAR casein, lactalbumin) resemble the status of the mam- 
mary glands before pregnancy. The pre-programmed epithelial 
cell death, known as 'apoptosis' is characterised by distinct 
morphological terations, including cytoplasm and chromatin 
condensation as well as nuclear segmentation. To obtain exper- 
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Fig. 2. Mammary gland tissue sections i olated from transgenic and 
normal animals were stained with Hoechst dye 33258. Tissue segments 
were isolated: (A) from a transgenic animal at the day 18 of pregnancy; 
(B) from a normal animal at the first day of lactation. 
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Fig. 3. DNA fragmentation in mammary gland cells of transgenic and normal animals: during pregnancy (day: 16 and 18), during lactation (day: 
1, 3, 5, 7) and after weaning (day: 2, 4, 6). C: DNA was extracted from a tail segment of a transgenic animal. Tissue segments were isolated from 
the mammary glands at the time indicated; chromosomal DNA was extracted and subjected to agarose gel electrophoresis. DNA was visualised by 
ethidium bromide staining. The standard DNA fragments (M) are indicated on the right in bp. 
imental evidence that the mammary gland involution of the 
transgenic animals during late pregnancy is caused by apopto- 
sis, tissue sections were stained with Hoechst dye 33258. As 
shown in Fig. 2A, the mammary gland of the transgenic animals 
undergoes extensive apoptosis on the day 18 of pregnancy. This 
is indicated by clusters of abnormal epithelial cells with con- 
densed nuclei, cytoplasmic condensation and nuclear fragmen- 
tation. Furthermore, large numbers of apoptotic ells are de- 
monstrable in the alveolar and ductal lumen, suggesting that 
these apoptotic ells are cast-off rom the alveoli. In contrast, 
mammary gland epithelial cells of the controls mainly exhibit 
a regular shape and apoptotic ells are almost not detectable 
in the alveolar and ductal lumen (Fig. 2B). 
The biochemical hallmark of apoptosis is the non-random 
DNA fragmentation. This oligonucleosomal DNA fragmenta- 
tion is specific for many forms of apoptosis including mammary 
gland involution [10-13]. To demonstrate further that prema- 
ture cell death accounts for the under-development of the mam- 
mary glands at late pregnancy and during the lactation period, 
the DNA was extracted from normal and transgenic mammary 
glands and subjected to agarose gel electrophoresis. As shown 
in Fig. 3, DNA fragmentation is already demonstrable in the 
mammary glands of the transgenic animals on the day 18 of 
pregnancy and continues during the early period of lactation. 
In contrast, no DNA fragmentation is demonstrable in the 
mammary gland of the normal animals during pregnancy or the 
entire lactation period. DNA fragmentation ccurs only two to 
four days after weaning, mediating the replacement of the epi- 
thelial cells by the adipose cells. These reults clearly demon- 
strate that the SV40 T-antigen acts as an intracellular inducer 
of apoptosis during late pregnancy, accounting at least in part 
for the milk-less phenomenon of the transgenic animals. 
So far it is not clear how SV40 T-antigen causes premature 
apoptosis. However, this feature is common for several other 
viral proteins uch as the papilloma virus 16 E7 and the adeno- 
virus EIA protein [14]. These are mainly nuclear proteins with 
a strong mitotic activity. Recent studies indicate that apoptosis 
is regulated by different genes and that the cell death machinery 
is likely to be located in the cytoplasm [15-17]. Therefore, we 
have reasons to believe that the T-antigen-induced premature 
gland involution is an indirect effect requiring the interplay 
with other cellular proteins. This assumption is in accordance 
with the concept hat apoptosis can be induced by activators 
of the cell cycle entry [6]. 
To test whether all epithelial cells are eliminated by apopto- 
sis, tissue sections were prepared from transgenic animals dur- 
ing the lactation period and after weaning. T-antigen staining 
experiments revealed that mammary glands of the transgenic 
animals contained multiple islands of T-antigen-positive mam- 
mary epithelial cells (data not shown). This indicates that the 
SV40 T-antigen has a dual function: it mediates pre-mature 
apoptosis during late pregnancy and it allows a significant 
number of mammary gland epithelial cell to escape apoptosis. 
As a consequence of this escape, T-antigen-positive c lls pro- 
gressively divide and all transgenic females develop T-antigen- 
positive tumors after the first pregnancy [7,18]. 
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